PT
Paul Tudor Jones II (Tudor Investment) disclosed decreased in Edwards Lifesciences Corp - US
Paul Tudor Jones II (Tudor Investment) filed a 13F change in Edwards Lifesciences Corp - US (2.8176E+112) on 2026-05-15, covering period end 2026-03-31.
Action
Decreased
Capital
$1,293,237 reported value
Institutional 13F Signals1 evidence source
Why it matters
This signal is anchored to the SEC filing date while retaining the underlying 13F period end.